| Treatment for scleroderma, there is no specific drug. The extent of the damage range of skin and visceral lesions is to determine the severity of the disease and the importance according to prognosis. Early diagnosis and early treatment to prevent disease progression for, you can get good results. Currently used mainly for treatment of anti-fibrosis, vasodilators, immunomodulatory, immunosuppressive agents and symptomatic treatment. Scleroderma is not incurable, but the natural history and prognosis of each patient's specific incidence of this disease and the involvement of the relevant organs, proper and reasonable treatment can improve the prognosis. Localized scleroderma patients with visceral damage occurred late, light condition, the prognosis is good. Small number of patients died due to pulmonary hypertension. It was reported that since the last scleroderma after diagnosis, 10-year survival rate is about 70%. Mainly diffuse scleroderma patients visceral damage occurs early, often involving vital organs such as heart, lung, kidney, etc., rapid progression, kidney failure, heart failure, secondary to pulmonary infection is the most common cause of death. Because angiotensin-converting enzyme inhibitors such as captopril, enalapril can effectively control blood pressure, reduce pulmonary hypertension and improve kidney function, so in recent years, long-term observations confirm those who adhere to the system treatment, disease control is better. Especially with the popularity of Rheumatology knowledge, the medical workers to raise awareness of rheumatic diseases, making diagnosis of rheumatic diseases, including scleroderma improved, patients can see a doctor early treatment, early diagnosis, early treatment, and can regularly follow-up examination, will be more improved the prognosis of scleroderma. With the rapid development of medical research, medical treatment will be more advanced. |
